This inventor holds 2 USPTO granted patents. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1976-1979.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JA (1976)
- Osaka, JP (1979)
Company Filing History:
Years Active: 1976-1979
Title: Tomonobu Umetani: Innovator in Chromone Derivatives
Introduction
Tomonobu Umetani is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of chemistry, particularly in the development of novel chromone derivatives. His work has implications for anti-allergic treatments, showcasing his innovative approach to medicinal chemistry.
Latest Patents
Umetani holds 2 patents that focus on chromone derivatives. His latest patents include the development of novel chromone derivatives, which are characterized by a specific general formula. These derivatives are designed to serve as intermediates for chromones that exhibit effective anti-allergic action. Additionally, he has worked on chromonealdehyde compounds and the processes for their production, further expanding the potential applications of his research.
Career Highlights
Tomonobu Umetani is associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work at Takeda has allowed him to explore innovative solutions in the field of medicinal chemistry. Umetani's research is recognized for its potential to improve therapeutic options for patients suffering from allergies.
Collaborations
Umetani has collaborated with notable colleagues, including Akira Nohara and Yasushi Sanno. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Tomonobu Umetani's contributions to the field of chemistry, particularly through his patents on chromone derivatives, highlight his role as an innovator. His work continues to pave the way for advancements in anti-allergic treatments, demonstrating the importance of research and collaboration in the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
